Cargando…

E-cadherin Plays a Role in Hepatitis B Virus Entry Through Affecting Glycosylated Sodium-Taurocholate Cotransporting Polypeptide Distribution

Hepatitis B virus (HBV) infection is a major cause of chronic liver disease and hepatocellular carcinoma. Current antiviral therapy does not effectively eradicate HBV and further investigations into the mechanisms of viral infection are needed to enable the development of new therapeutic agents. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Qin, Zhang, Feifei, Duan, Liang, Wang, Bo, Ye, Yuanyuan, Li, Pu, Li, Dandan, Yang, Shengjun, Zhou, Lan, Chen, Weixian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056903/ https://www.ncbi.nlm.nih.gov/pubmed/32175289 http://dx.doi.org/10.3389/fcimb.2020.00074

Ejemplares similares

Age‐dependent glycosylation of the sodium taurocholate cotransporter polypeptide: From fetal to adult human livers
por: Sargiacomo, Camillo, et al.
Publicado: (2018)

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019)

Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
por: Salhab, Ahmad, et al.
Publicado: (2022)

Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B
por: Zhao, Kaitao, et al.
Publicado: (2018)

Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide
por: Witzigmann, Dominik, et al.
Publicado: (2019)

Clinical and histopathologic features of sodium taurocholate cotransporting polypeptide deficiency in pediatric patients
por: Dong, Chen, et al.
Publicado: (2019)

Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency
por: Deng, Mei, et al.
Publicado: (2016)

Blocking Sodium‐Taurocholate Cotransporting Polypeptide Stimulates Biliary Cholesterol and Phospholipid Secretion in Mice
por: Roscam Abbing, Reinout L.P., et al.
Publicado: (2019)

Effect of mTOR inhibitors on sodium taurocholate cotransporting polypeptide (NTCP) function in vitro
por: Saran, Chitra, et al.
Publicado: (2023)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
por: Yan, Huan, et al.
Publicado: (2012)

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide
por: Kaneko, Manabu, et al.
Publicado: (2018)

Monozygotic Twins Suffering From Sodium Taurocholate Cotransporting Polypeptide Deficiency: A Case Report
por: Tan, Hui-Jun, et al.
Publicado: (2018)

Correction: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
por: Yan, Huan, et al.
Publicado: (2014)

Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP)
por: Veloso Alves Pereira, Isabel, et al.
Publicado: (2015)

Upregulation of sodium taurocholate cotransporter polypeptide during hepatogenic differentiation of umbilical cord matrix mesenchymal stem cells facilitates hepatitis B entry
por: Sargiacomo, Camillo, et al.
Publicado: (2017)

Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques
por: Burwitz, Benjamin J., et al.
Publicado: (2017)

Clinical features of sodium-taurocholate cotransporting polypeptide deficiency in pediatric patients: case series and literature review
por: Zou, Ting-Ting, et al.
Publicado: (2021)

Na(+)‐taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice
por: Slijepcevic, Davor, et al.
Publicado: (2018)

Hepatic Expression of the Na(+)-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation
por: Tremmel, Roman, et al.
Publicado: (2022)

N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection
por: Appelman, Monique D., et al.
Publicado: (2017)

De novo mutation loci and clinical analysis in a child with sodium taurocholate cotransport polypeptide deficiency: A case report
por: Liu, Hui-Yan, et al.
Publicado: (2021)

Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide
por: Okuyama-Dobashi, Kaori, et al.
Publicado: (2015)

Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver
por: Nakabori, Tasuku, et al.
Publicado: (2016)

Sodium Taurocholate Cotransporting Polypeptide (NTCP) Deficiency Hidden Behind Citrin Deficiency in Early Infancy: A Report of Three Cases
por: Lin, Hui, et al.
Publicado: (2019)

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
por: Watashi, Koichi, et al.
Publicado: (2014)

Sodium Taurocholate Stimulates Campylobacter jejuni Outer Membrane Vesicle Production via Down-Regulation of the Maintenance of Lipid Asymmetry Pathway
por: Davies, Cadi, et al.
Publicado: (2019)

Calnexin Depletion by Endoplasmic Reticulum Stress During Cholestasis Inhibits the Na(+)‐Taurocholate Cotransporting Polypeptide
por: Robin, Marion J.D., et al.
Publicado: (2018)

Structural Plasticity Is a Feature of Rheostat Positions in the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP)
por: Ruggiero, Melissa J., et al.
Publicado: (2022)

Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status
por: Ezzikouri, Sayeh, et al.
Publicado: (2017)

Specific Binding and Endocytosis of Liposomes to HEK293T Cells via Myrisoylated Pre-S1 Peptide Bound to Sodium Taurocholate Cotransporting Polypeptide
por: Hinuma, Shuji, et al.
Publicado: (2022)

A clinically relevant polymorphism in the Na(+)/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat position
por: Ruggiero, Melissa J., et al.
Publicado: (2020)

Tyrosine 146 of the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

The Lipid Raft Component Stomatin Interacts with the Na(+) Taurocholate Cotransporting Polypeptide (NTCP) and Modulates Bile Salt Uptake
por: Appelman, Monique D., et al.
Publicado: (2020)

Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice
por: Slijepcevic, Davor, et al.
Publicado: (2017)

Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide
por: He, Wenhui, et al.
Publicado: (2015)

Establishment of a human cell line with a surface display system for screening and optimizing Na(+)-taurocholate cotransporting polypeptide-binding peptides
por: Wang, Pei-yun, et al.
Publicado: (2022)

Multitasking Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

Sodium taurocholate cotransporting polypeptide (NTCP) deficiency: Identification of a novel SLC10A1 mutation in two unrelated infants presenting with neonatal indirect hyperbilirubinemia and remarkable hypercholanemia
por: Qiu, Jian-Wu, et al.
Publicado: (2017)

Streptolysin S targets the sodium-bicarbonate cotransporter NBCn1 to induce inflammation and cytotoxicity in human keratinocytes during Group A Streptococcal infection
por: Hammers, Daniel E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gvic5ge5p4pd4epm2d03174r1i